Status: Recruiting
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
This is a multicenter screening study to characterize the prevalence of the KIT D816V mutation in participants with suspected clonal mast cell disease.
Participants needed: 750
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Blueprint Medicines CorporationUpdated: Aug 12, 2026Locations: 22
Eligibility criteria
Documented anaphylaxis due to Hymenoptera venom with cardiovascular symptoms or [+9]
Monoclonal mast cell activation syndrome with a known KIT mutation [+3]